×
AllImagesVideosMaps News Shopping Books
Search tools
Past month
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
All results
Clear

patritumab deruxtecan (U3-1402) / Daiichi Sankyo, Merck (MSD)

delta.larvol.com › Products
May 21, 2024 · HERTHENA-PanTumor01: A global, multicohort, phase 2 trial of HER3-DXd in relapsed/refractory metastatic solid tumors. (ASCO 2024) - P2 | "HER3-DXd is a ...

ifinatamab deruxtecan (DS-7300) / Daiichi Sankyo, Merck (MSD)

delta.larvol.com › products
May 21, 2024 · ... HERTHENA-PanTumor01 phase 2 trial (TPS3164) evaluating patritumab deruxtecan (HER3-DXd) in patients with locally advanced or metastatic solid tumors, and ...